We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
The current UBI market cap is 35.04M. The company's latest EPS is AUD -0.0317 and P/E is -5.05.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Revenue | 6.9M | 3.2M | 5.78M | 4.53M | 6.63M |
| Operating Income | -7.54M | -7.61M | -10.71M | -29.95M | -7.27M |
| Net Income | -4.85M | -7.64M | -10.51M | -26.86M | -6.74M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Assets | 62.66M | 56.38M | 44.5M | 46.15M | 29.97M |
| Total Liabilities | 17.27M | 18.41M | 16.89M | 20.05M | 10.47M |
| Total Equity | 45.39M | 37.98M | 27.61M | 26.09M | 19.51M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Operating | 33.24M | -8.29M | -9.9M | -14.7M | -14.62M |
| Investing | -10.28M | -372k | -665k | -1.57M | -1.47M |
| Financing | 3k | 44k | 96k | 25.01M | -83k |
| Market Cap | 35.04M |
| Price to Earnings Ratio | -5.05 |
| Price to Sales Ratio | 5.13 |
| Price to Cash Ratio | 3.32 |
| Price to Book Ratio | 1.74 |
| Dividend Yield | - |
| Shares Outstanding | 212.37M |
| Average Volume (1 week) | 118.4k |
| Average Volume (1 Month) | 445.86k |
| 52 Week Change | -41.07% |
| 52 Week High | 0.32 |
| 52 Week Low | 0.135 |
| Spread (Intraday) | 0.02 (8.33%) |
| Company Name | Universal Biosensors Inc |
| Address |
1 corporate avenue melbourne, victoria 3178 |
| Website | https://www.universalbiosensors.com |
| Industry | in vitro,in vivo diagnostics (2835) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
